ClinicalTrials.gg
RecruitingNCT06102954SAFE-TECHUpdated Sep 19, 2024

A Multi-domain and Multi-component Falls Intervention Program for Community- Dwelling Older Adults: SAFE-TECH

An interventional study of Falls prevention intervention including exercise and educational components in Fall Prevention and Fall Injury, sponsored by Duke-NUS Graduate Medical School. Recruiting at 1 site in Singapore. Open to participants aged 60 Years to 95 Years. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by Duke-NUS Graduate Medical School · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Feb 2026, 8 months ago, but the record still lists the study as recruiting.
  • Started Mar 2024; still recruiting 2 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Randomized
Ages
60 Years to 95 Years
Sex
All
01

Study summary

Background: Falls and fall-related injuries among older adults are a significant health problem that results in injuries, prolonged hospitalisation, reduced mobility, and poorer quality of life. Previous falls prevention programs have demonstrated the effectiveness of multi-component falls prevention interventions in improving functional outcomes and reducing falls compared to usual care. A previous trial of a tailored multi-component falls intervention program for older adults recruited from the emergency department (SAFE) found that there is significant heterogeneity in terms of falls risk factors in high falls risk older adults. Thus, the effectiveness of SAFE in participants with poorer cognitive function or had more comorbidities were less effective and less cost-effective. Therefore, the aim of this trial is to demonstrate the effectiveness of a technology-enhanced, multi-domain and multi-component falls prevention intervention in reducing number of fallers and injurious fallers among older adults with elevated fall risk.

Hypothesis: Using novel wearable technologies to a) identify older adults who are at high risk of falls and more likely to benefit from a multi-component intervention and b) tailor the exercise and educational components by giving individualized biofeedback will improve the effectiveness of an enhanced multi-domain, multi-component falls intervention program for community dwelling older adults.

Methodology: This study is a randomized controlled trial aimed at demonstrating the effectiveness of a technology-enhanced, multi-domain and multi-component falls prevention intervention (SAFE-TECH) in community- dwelling older adults with elevated fall risk compared with usual care. Participants in both arms are selected based on questionnaire based and wearable sensor based predictions of their falls risk. Participants in the intervention arm will receive a 12-week active falls intervention program consisting of exercise and educational components, with detailed biofeedback of their functional status.

Read the detailed description

Objective: To demonstrate the feasibility and effectiveness of a technology-enhanced multi-domain, multi-component falls intervention program consisting of screening, assessments, progressive physical therapy and education to reduce falls and injurious falls in community-dwelling older adults in Singapore.

Methodology: This study is a multi-center, two-arm, parallel group, randomized controlled trial with 400 participants allocated to the intervention and control arm in a 1:1 ratio. In the intervention arm, participants will be enrolled in a multi-domain, multi-component falls intervention program that consists of exercise and educational components for 12 weeks. The exercise components are progressive and tailored to individual falls risk factors. Exercises aim to improve 5 domains of physical function: strength, balance, flexibility, coordination, and aerobic endurance. The educational components focus on the management of fall risk factors such as polypharmacy, nutrition, pain, orthostatic hypotension, poor vision, and environmental hazards. The education sessions also provide feedback based on individualized falls risk assessments. After the 12-week active intervention phase, the participants in the intervention arm will enter a 9-month maintenance phase where they will be encouraged to maintain their physical activity, and continue practicing falls prevention behavior.

The study will collect information from both intervention and control arm on their living situation, cognitive function, quality of life, general health, falls history, behavioral and psychosocial characteristics, handgrip strength, orthostatic hypotension, ankle mobility, physical function (Short Performance Physical Battery) and gait assessment (ZurichMOVE system of wearable gait sensors) at baseline, 3rd-months and 12th-months into the study. Monthly follow-up calls will be done to collect participants' fall status, healthcare utilisation, physical activity, and exercise self- efficacy over the 12-month period.

02

Conditions studied

  • Fall Prevention
  • Fall Injury

Keywords

  • Fall
  • Injurious fall
  • Falls Prevention Intervention
03

In context

Lead sponsor

Duke-NUS Graduate Medical School is the lead sponsor of 63 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 95 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 60 to 95 years
  • Ambulatory with or without walking aid
  • Does not possess cognitive impairment with an Abbreviated Mental Score-Singapore >=6

Exclusion criteria

Exclusion Criteria:

  • Had any significant morbidity:

    • Congestive Heart Failure in the past 6 months
    • Myocardial Infarction in the past 6 months
    • Stroke (Intra-Cranial Haemorrhage) in the past 6 months
    • Concussion or Head Injury in the past 6 months
    • End Stage Renal Failure requiring dialysis
    • Severe Asthma or (COPD) (e.g. Chronic Lung Disease or Chronic Bronchitis or Emphysema), experiencing symptoms at rest or with mild activity
    • Lower Limb Fractures in the past 6 months
  • Blindness, with or without the use of any visual aids
  • Deafness, with or without the use of any hearing aids
  • Currently experiencing one of the following:

    • Chest discomfort, or
    • Breathlessness, or
    • Dizziness, or
    • Profuse sweating
  • Had an amputation of any part of the lower limbs except toes, or had an amputation of any toes in the last 30 days
  • Currently in a long-term institution
  • Currently participating in any randomized clinical or controlled trial that involves physical exercise
  • Unwilling to complete the baseline gait assessment, or complete less than 3 minutes of the 5-minute baseline gait assessment
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
400 participants (estimated)

Study arms

  • Experimental
    Intervention group

    12-weeks active intervention session includes exercise and educational components. 9 months maintenance phase

    Other: Falls prevention intervention including exercise and educational components

  • No intervention
    Control group

    No intervention for 12 months during intervention period.

Interventions

  • OtherFalls prevention intervention including exercise and educational components

    This includes five domains of exercise (strength, balance, flexibility, coordination, and endurance) and educational components to manage other falls risk factors (polypharmacy, nutrition, pain, orthostatic hypotension, poor vision and environmental hazard evaluations).

06

What researchers measure

Primary outcomes

  1. Number of Fallers

    Evaluation of number of falls in 12 months

    Time frame: Baseline, Monthly phone call follow-up for 1 year, 12th-month after first intervention session

Secondary outcomes

  1. Number of Injurious Fallers

    Evaluation of number of injurious falls in 12 months

    Time frame: Baseline, Monthly phone call follow-up for 1 year, 12th-month after first intervention session

  2. Physical Function

    Evaluation of change in physical function using Short Physical Performance Battery test (SPPB) \[range from 0 to 12 score\].A higher score represents a higher physical function level.

    Time frame: Baseline, 3rd-month and 12th-month after first intervention session

  3. Fear of Falling

    Evaluation of change in falls efficacy using Iconographical Falls Efficacy Scale (Icon-FES). A higher value represents a high concern for falling.

    Time frame: Baseline, 3rd-month and 12th-month after first intervention session

  4. Practice of Falls Prevention Behaviours

    Evaluation of change in practice of falls prevention behaviours by using Falls Behavioral Scale (FaB). A higher value represents a better practice of falls prevention behaviours.

    Time frame: Baseline, 3rd-month and 12th-month after first intervention session

07

Study locations

1 of 1 sites recruiting
  • Centre for Ageing Research & Education
    Singapore, 169857, Singapore
    Recruiting
    • · Contact+65 6516 7666
08

References and documents

Publications

  • Matchar DB, Eom K, Duncan PW, Lee M, Sim R, Sivapragasam NR, Lien CT, Ong MEH. A Cost-Effectiveness Analysis of a Randomized Control Trial of a Tailored, Multifactorial Program to Prevent Falls Among the Community-Dwelling Elderly. Arch Phys Med Rehabil. 2019 Jan;100(1):1-8. doi: 10.1016/j.apmr.2018.07.434. Epub 2018 Aug 27. PubMed 30165053 ↗
  • Matchar DB, Duncan PW, Lien CT, Ong MEH, Lee M, Gao F, Sim R, Eom K. Randomized Controlled Trial of Screening, Risk Modification, and Physical Therapy to Prevent Falls Among the Elderly Recently Discharged From the Emergency Department to the Community: The Steps to Avoid Falls in the Elderly Study. Arch Phys Med Rehabil. 2017 Jun;98(6):1086-1096. doi: 10.1016/j.apmr.2017.01.014. Epub 2017 Feb 12. PubMed 28202383 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Mar 2024 (actual). Primary completion is estimated for Feb 2026, 23 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 15, 2023
First posted
Oct 26, 2023
StartActual
Mar 1, 2024
Primary completionEst.
Feb 28, 2026
CompletionEst.
Feb 28, 2026
Last update
Sep 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06102954
Lead sponsor
Duke-NUS Graduate Medical School
Responsible party
David Bruce Matchar (Professor, Duke-NUS Graduate Medical School) — Principal investigator
First posted
Oct 26, 2023
Start date
Mar 1, 2024
Primary completion
Feb 28, 2026 (estimated)
Completion
Feb 28, 2026 (estimated)
Last update
Sep 19, 2024

Study contacts

Jing Wen Goh
Contact
jingwen_goh@duke-nus.edu.sg
+65 6601 3889
Kok Yang Tan
Contact
kokyang.tan@duke-nus.edu.sg
Matchar David Bruce
principal investigator · Duke-NUS Graduate Medical School

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion